Sarcoidosis is an uncommon inflammatory disorder of unknown cause defined by characteristic granulomas involving the skin in 25% to 30% of patients. Thus, dermatologists may play a role in initial diagnosis or long-term disease management. Unfortunately, there exists no standardized algorithm for managing cutaneous sarcoidosis. In their article, Steen and English1 present minocycline as a potential addition to the therapeutic armamentarium.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados